What antibiotics are used to treat bacterial tonsillitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Bacterial Tonsillitis

First-Line Treatment

Penicillin V (phenoxymethylpenicillin) or amoxicillin for 10 days is the first-line antibiotic treatment for confirmed bacterial tonsillitis caused by Group A Streptococcus. 1, 2, 3

Preferred First-Line Regimens

  • Penicillin V remains the gold standard with five decades of proven efficacy and no documented resistance development 3

    • Pediatric dosing: 250 mg two or three times daily for 10 days 3
    • Adult dosing: 250 mg four times daily OR 500 mg twice daily for 10 days 3, 4
    • Universal susceptibility of Group A Streptococcus makes this the most reliable choice 1
  • Amoxicillin is preferred in younger children due to better taste and suspension availability 3

    • Pediatric dosing: 50 mg/kg once daily (maximum 1,000 mg) for 10 days 3
    • Adult dosing: 250 mg four times daily OR 500 mg twice daily for 10 days 3
    • Achieves peak blood levels of 5.5-7.5 mcg/mL within 1-2 hours 5
  • Penicillin G benzathine (intramuscular) is a single-dose alternative for compliance concerns 3

    • 600,000 units for patients <27 kg 3
    • 1,200,000 units for patients ≥27 kg 3

Critical Treatment Duration

  • The full 10-day course is essential for penicillin and amoxicillin to maximize bacterial eradication and prevent rheumatic fever 2, 3
  • Short courses (5 days) of standard-dose penicillin are less effective and should be avoided 2
  • Antibiotics reduce rheumatic fever risk by 73% (RR 0.27) and peritonsillar abscess risk by 85% (RR 0.15) 3

Second-Line Treatment Options

For Penicillin-Allergic Patients (Non-Anaphylactic)

  • Cephalexin is the preferred second-choice antibiotic based on lower relapse rates and narrow spectrum 2, 3
    • Dosing: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 3
    • First-generation cephalosporins (cefadroxil is also acceptable) for 10 days 2

For Severe Penicillin Allergy (Anaphylactic)

  • Clarithromycin should be used when severe penicillin allergy exists 2, 3

    • Pediatric dosing: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 3
    • Major caveat: Effectiveness is significantly compromised in areas with high macrolide resistance 3, 6
    • In one study, clarithromycin failed to eradicate 81-86% of resistant isolates 6
  • Azithromycin is an alternative macrolide with more convenient dosing 2, 7

    • Pediatric dosing: 12 mg/kg once daily for 5 days 8
    • Achieved 95% bacteriologic eradication at Day 14 versus 73% with penicillin V in FDA trials 8
    • Once-daily dosing improves compliance 7
  • Clindamycin is another option for severe allergy 2, 3

    • Dosing: 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 3

Treatment Failures and Recurrent Tonsillitis

When Initial Penicillin Therapy Fails

  • Amoxicillin-clavulanate (Augmentin) achieves higher eradication rates in penicillin treatment failures 1

    • Adult dosing: 500 mg amoxicillin/125 mg clavulanate three times daily for 10 days 1
    • Pediatric dosing: 45 mg/kg/day of amoxicillin component divided into 2-3 doses 1
    • High-dose pediatric regimen: 80-90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses for children with risk factors 1
    • Broader coverage addresses beta-lactamase producing organisms 1, 9
  • Reassess patients showing no improvement within 48-72 hours and consider switching to amoxicillin-clavulanate 1

For Documented Recurrent GAS Tonsillitis

  • Clindamycin is recommended for recurrence within 2 weeks of completing standard therapy 2

    • Dosing: 20-30 mg/kg/day in 3 doses (maximum 300 mg/dose) for 10 days 2
  • Alternative regimens include amoxicillin-clavulanate at 40 mg amoxicillin/kg/day in 3 doses (maximum 2000 mg/day) for 10 days 2

  • Penicillin with rifampin: Penicillin V 50 mg/kg/day in 4 doses for 10 days plus rifampin 20 mg/kg/day in 1 dose for the last 4 days 2

Critical Pitfalls to Avoid

  • Never treat without confirming GAS infection through rapid antigen detection testing (RADT) or throat culture 2
  • Do not use inadequate treatment duration (<10 days) for penicillin, amoxicillin, or clarithromycin, as this increases treatment failure risk 2, 3
  • Check local macrolide resistance patterns before prescribing clarithromycin or azithromycin, as resistance is geographically variable 3, 6
  • Avoid routine follow-up cultures for asymptomatic patients who completed appropriate therapy 2
  • Consider chronic GAS carriage in patients with recurrent positive tests, as up to 20% of school-age children may be asymptomatic carriers experiencing viral pharyngitis 2
  • Do not prescribe broad-spectrum antibiotics when narrow-spectrum penicillins are effective for confirmed GAS 2

Diagnostic Confirmation Required

  • Antibiotics should only be prescribed for confirmed bacterial cases through RADT and/or throat culture 2
  • Bacterial tonsillitis is characterized by sudden onset sore throat, fever >38°C, tonsillar exudates, tender anterior cervical lymphadenopathy, and absence of cough 2
  • Viral tonsillitis lacks high fever, tonsillar exudate, and cervical lymphadenopathy 2

References

Guideline

Treatment of Bacterial Tonsillitis with Augmentin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Viral from Bacterial Tonsillitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Bacterial Tonsillitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Macrolides in the management of streptococcal pharyngitis/tonsillitis.

The Pediatric infectious disease journal, 1997

Research

Acute tonsillitis.

Infectious disorders drug targets, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.